Guangxi LiuYao Group

Guangxi LiuYao Group operates as a leading regional pharmaceutical distributor in China with a focus on hospital sales, retail pharmacies, and value-added smart medicine services. The company does not conduct its own drug R&D but distributes a wide range of pharmaceutical products across China. It has shown consistent revenue growth in wholesale and retail segments over recent years. While it does have some industrial operations related to pharmaceuticals production/distribution logistics infrastructure, it does not engage in innovative drug discovery or clinical development typical of biotech/pharma companies with pipelines. The group’s main activities are wholesale supply to hospitals/clinics and operation of pharmacy chains throughout China. Its “smart medicine” initiatives focus on digitalizing logistics/services rather than developing new therapeutics. No evidence was found that the company develops its own drugs or has an internal clinical-stage pipeline—it acts primarily as a channel partner for established pharma brands within mainland China.